Previous close | 1.2500 |
Open | 0.8000 |
Bid | 0.0000 |
Ask | 4.7000 |
Strike | 820.00 |
Expiry date | 2023-06-16 |
Day's range | 0.5500 - 1.3000 |
Contract range | N/A |
Volume | |
Open interest | 59 |
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.
Over the past year, many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders sold a significant stake in the company...
Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog.